Bibliographic information
GuidelineWHO guidelines on tuberculosis infection prevention and control: 2019 update
Year of Publication2019
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
In patients with confirmed rifampicin-susceptible and isoniazidresistant tuberculosis, it is not recommended to add streptomycin or other injectable agents to the treatment regimen
Recommended against
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.
Year2022
InstitutionWHO